ONCIMMUNE HOLDINGS PLC(ONC.UK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

ONCIMMUNE HOLDINGS PLC(ONC.UK)

24.00+1.00+4.35%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
ONCIMMUNE HOLDINGS PLC
所属市场
LSE
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.oncimmune.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Oncimmune Holdings plc develops and commercializes products to diagnose cancer in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a blood test for early detection of lung cancer. The company also develops EarlyCDT-Liver, a blood test for the early detection of hepatocellular carcinoma in high-risk patients with liver lesions of all sizes; SeroTag, a platform that is used to discover and validate biomarkers and develop precision diagnostic tools from minimally-invasive liquid biopsies; and NavigAID for autoimmune diseases. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.

分时
5日
日
周
月

最高

24.00

今开

24.00

量比

8.56

最低

24.00

昨收

23.00

换手率

0.06%

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

老虎社区侵权投诉指引

中国互联网举报中心·北京互联网举报中心

网络谣言曝光台·扫黄打非举报中心

网络110报警服务

© 2018-2024 老虎社区版权所有

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

qrcode

关注我们

{"pagemeta":{"title":"ONCIMMUNE HOLDINGS PLC(ONC.UK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ONCIMMUNE HOLDINGS PLC(ONC.UK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ONCIMMUNE HOLDINGS PLC,ONC.UK,ONCIMMUNE HOLDINGS PLC股票,ONCIMMUNE HOLDINGS PLC股票老虎,ONCIMMUNE HOLDINGS PLC股票老虎国际,ONCIMMUNE HOLDINGS PLC行情,ONCIMMUNE HOLDINGS PLC股票行情,ONCIMMUNE HOLDINGS PLC股价,ONCIMMUNE HOLDINGS PLC股市,ONCIMMUNE HOLDINGS PLC股票价格,ONCIMMUNE HOLDINGS PLC股票交易,ONCIMMUNE HOLDINGS PLC股票购买,ONCIMMUNE HOLDINGS PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ONCIMMUNE HOLDINGS PLC(ONC.UK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ONCIMMUNE HOLDINGS PLC(ONC.UK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"ONC.UK","data":{"stockData":{"symbol":"ONC.UK","market":"UK","secType":"STK","nameCN":"ONCIMMUNE HOLDINGS PLC","latestPrice":24,"timestamp":1714375559426,"preClose":23,"halted":0,"volume":30000,"delay":15,"floatShares":51910670,"shares":74103899,"eps":5.66,"marketStatus":"交易中","marketStatusCode":2,"change":1,"latestTime":"04-29 08:25:59 BST 延时","open":24,"high":24,"low":24,"amount":720000,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":5.66,"exchange":"LSE","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1714404600000},"adr":0,"adjPreClose":23,"adrRate":0,"openAndCloseTimeList":[[1714374000000,1714404600000]],"volumeRatio":8.55725,"nameEN":"ONCIMMUNE HOLDINGS PLC","tradeCurrency":"GBX","tradeService":"SETSqx","exchangeMarketSize":3000},"tweetData":null,"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://www.oncimmune.com","stockEarnings":[{"period":"1week","weight":-0.1429},{"period":"1month","weight":0.1765},{"period":"3month","weight":-0.04},{"period":"6month","weight":0.459},{"period":"1year","weight":-0.4074},{"period":"ytd","weight":-0.0769}],"compareEarnings":[{"period":"1week","weight":0.0309},{"period":"1month","weight":0.0291},{"period":"3month","weight":0.077},{"period":"6month","weight":0.1342},{"period":"1year","weight":0.0781},{"period":"ytd","weight":0.0645}],"compareStock":{"symbol":"ISF.UK","name":"FTSE100 ETF"},"description":"Oncimmune Holdings plc develops and commercializes products to diagnose cancer in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a blood test for early detection of lung cancer. The company also develops EarlyCDT-Liver, a blood test for the early detection of hepatocellular carcinoma in high-risk patients with liver lesions of all sizes; SeroTag, a platform that is used to discover and validate biomarkers and develop precision diagnostic tools from minimally-invasive liquid biopsies; and NavigAID for autoimmune diseases. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.006409},{"month":2,"riseRate":0.5,"avgChangeRate":0.044328},{"month":3,"riseRate":0.375,"avgChangeRate":-0.046196},{"month":4,"riseRate":0.75,"avgChangeRate":0.118102},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.040873},{"month":6,"riseRate":0.375,"avgChangeRate":-0.028827},{"month":7,"riseRate":0.375,"avgChangeRate":0.07789},{"month":8,"riseRate":0.5,"avgChangeRate":-0.011127},{"month":9,"riseRate":0.25,"avgChangeRate":-0.081322},{"month":10,"riseRate":0.375,"avgChangeRate":-0.060279},{"month":11,"riseRate":0.5,"avgChangeRate":0.028434},{"month":12,"riseRate":0.5,"avgChangeRate":0.028056}],"exchange":"LSE","name":"ONCIMMUNE HOLDINGS PLC","nameEN":"ONCIMMUNE HOLDINGS PLC"},"aProfile":null}}}